NCT06544291View on ClinicalTrials.gov

Combined THC and CBD for OUD and Chronic Pain

PHASE2RecruitingINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

January 28, 2028

Study Completion Date

January 28, 2028

Conditions
Chronic PainOpioid Use Disorder
Interventions
DRUG

CBD 300mg

3 Nantheia™ (100mg) softgel capsules and 3 placebo (0mg) softgel capsules will be administered to participants on one of the three test session days.

DRUG

CBD 600mg

6 Nantheia™ (100mg) softgel capsules will be administered to participants on one of the three test session days.

DRUG

Placebo 0mg

6 placebo (0 mg) softgel capsules will be administered to participants on one of the three test session days.

Trial Locations (1)

06519

RECRUITING

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Yale University

OTHER